Strict in vivo specificity of the Bcl11a erythroid enhancer.
about
Functional interrogation of non-coding DNA through CRISPR genome editing.Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies.Comparative analysis of three-dimensional chromosomal architecture identifies a novel fetal hemoglobin regulatory element.Genome Editing for Sickle Cell Disease: A Little BCL11A Goes a Long Way.
P2860
Strict in vivo specificity of the Bcl11a erythroid enhancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Strict in vivo specificity of the Bcl11a erythroid enhancer.
@en
Strict in vivo specificity of the Bcl11a erythroid enhancer.
@nl
type
label
Strict in vivo specificity of the Bcl11a erythroid enhancer.
@en
Strict in vivo specificity of the Bcl11a erythroid enhancer.
@nl
prefLabel
Strict in vivo specificity of the Bcl11a erythroid enhancer.
@en
Strict in vivo specificity of the Bcl11a erythroid enhancer.
@nl
P2093
P2860
P50
P1433
P1476
Strict in vivo specificity of the Bcl11a erythroid enhancer
@en
P2093
Donyell M Croney
Falak Sher
Luciano C Greig
Minh Nguyen
P2860
P304
P356
10.1182/BLOOD-2016-08-736249
P407
P50
P577
2016-10-05T00:00:00Z